Wall Street Wrap: Humana CEO Says “the Priority Is Not Growth”
Also: Nutex wants to speed up hospital development and a PE firm is buying Cross Country Healthcare.
Read More
Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases
Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon. Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. The post Novo Nordisk Bets $200M on Triple-Targeting Drug for…
The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through Breaks
The next wave of radiology AI value will come from closed-loop follow-up. An actionable finding should start a pathway with a measurable end state: the follow-up exam is completed, the referral is completed, or the recommendation is clinically resolved with a documented rationale. The post The Last Mile Problem in AI Radiology: Detection Improves, Follow-Through…
For Rehab Providers Outcomes Are the Strategy: Not Just the Scorecard
Outcomes are no longer a nice-to-have or a post-hoc justification for care provided. They are a central currency of care in a system that’s shifting faster than ever toward accountability. The post For Rehab Providers Outcomes Are the Strategy: Not Just the Scorecard appeared first on MedCity News.
Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare
Data is not optional; it is essential to financial stability and strategic growth. The organizations that thrive will be those that use data to lead, not follow. The post Data-Driven Decisions: Unlocking Strategic Financial Performance in Healthcare appeared first on MedCity News.
KFF Health Tracking Poll September 2024: Support for Reducing Prescription Drug Prices Remains High, Even As Awareness of IRA Provisions Lags
More than two years ago President Biden signed into law Medicare drug pricing provisions in the Inflation Reduction Act. KFF’s September Health Tracking Poll examines voter’s views on these provisions and finds that large majorities of voters are unaware of the provisions despite reporting support for them.
A New Prescription for Hyperemesis Gravidarum: Why We Should Rethink “Morning Sickness”
Far more severe than typical “morning sickness,” HG locks women in a debilitating cycle of nausea, vomiting, and dehydration, which can lead to serious health complications, including weight loss, neurological defects in infants, and even maternal suicide. The post A New Prescription for Hyperemesis Gravidarum: Why We Should Rethink “Morning Sickness” appeared first on MedCity…
Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target
Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…
Capping Per Enrollee Spending Could Reduce Federal Medicaid Expenditures by $532 billion to Nearly $1 Trillion Over 10 Years Depending on How States Respond and Result in as Many as 15 Million People Losing Medicaid Coverage by 2034
As Congress considers ways to cut Medicaid spending to help finance the extension of federal tax cuts, a new KFF analysis finds that imposing a cap on federal spending per Medicaid enrollee—known as a “per capita cap”—could trigger a decrease in federal Medicaid spending over a 10-year period of $532 billion to almost $1 trillion,…More
Proposed Medicaid Federal Match Penalty for States that Cover Undocumented Immigrants with Their Own Funds: State-by-State Estimates
This analysis examines the potential impacts of a provision in the House reconciliation bill that proposes reducing the federal matching rate for the Affordable Care Act (ACA) Medicaid expansion population from 90% to 80% for states that either provide health coverage or financial assistance to purchase health coverage to individuals who are not lawfully residing…